Keyphrases
Competing Endogenous RNA (ceRNA)
100%
Pancreatic Adenocarcinoma
100%
RNA Sequencing (RNA-seq)
100%
Signaling Activity
100%
Gene Expression
100%
Signaling Genes
100%
Adenocarcinoma Cells
100%
Tumor
66%
Murine Xenografts
33%
Basal-like Phenotype
33%
Microelectrophoresis
33%
Normal Mixture
33%
KRAS Pathway
33%
RNA Capture
33%
Pathway Expression
33%
Microsampling
33%
Catalytic Activity
33%
Targeted Therapeutics
33%
Ductal Adenocarcinoma
33%
Clinical Assay
33%
Human Tumors
33%
Platform Technology
33%
Kinase Signaling
33%
Kinase Activity
33%
Interdisciplinary Research Teams
33%
Capillary Electrophoresis
33%
Size Limit
33%
Cellular Heterogeneity
33%
Precision Medicine
33%
Signaling Pathway
33%
Tumor Cells
33%
Cell-derived
33%
Adenocarcinoma
33%
Therapeutic Decision-making
33%
Complex Mixtures
33%
Pancreatic Cells
33%
Molecular Profiling
33%
KRAS mutation
33%
Cell Platform
33%
Medicine and Dentistry
Pancreas Adenocarcinoma
100%
RNA Sequencing
100%
Neoplasm
100%
Gene Expression
100%
Adenocarcinoma
66%
Drug Mixture
33%
Kinase Signaling
33%
Molecular Profiling
33%
Xenograft
33%
Phosphotransferase
33%
RNA Sequence
33%
Personalized Medicine
33%
Microelectrophoresis
33%
Kinase
33%
Tumor Cell
33%
Messenger RNA
33%
Cell Signaling Pathway
33%
Diseases
33%
Biochemistry, Genetics and Molecular Biology
Gene Expression
100%
RNA Sequencing
100%
KRAS
66%
Phosphotransferase
66%
Kinase
66%
Enzymatic Activity
33%
RNA Sequence
33%
RNA
33%
Messenger RNA
33%